Metagenomi Therapeutics
48 hedge funds and large institutions have $8.65M invested in Metagenomi Therapeutics in 2026 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 15 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
40% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 15
58% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 12
Holders
48
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$594K | |
| 2 | +$248K | |
| 3 | +$130K | |
| 4 |
Two Sigma Investments
New York
|
+$86K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$81.2K |
Top Sellers
| 1 | -$439K | |
| 2 | -$250K | |
| 3 | -$105K | |
| 4 |
Millennium Management
New York
|
-$101K |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$80.2K |
